These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35274800)

  • 21. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
    Khammanivong A; Gopalakrishnan R; Dickerson EB
    Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
    Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
    Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
    Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
    Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
    Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
    Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas.
    Baschnagel AM; Tonlaar N; Eskandari M; Kumar T; Williams L; Hanna A; Pruetz BL; Wilson GD
    J Oral Pathol Med; 2017 Mar; 46(3):208-213. PubMed ID: 27442811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
    Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
    BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.
    Wang SJ; Bourguignon LY
    Am J Pathol; 2011 Mar; 178(3):956-63. PubMed ID: 21356346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy.
    Slavik M; Shatokhina T; Sana J; Ahmad P; Kazda T; Selingerova I; Hermanova M; Cervena R; Novotny T; Burkon P; Smilek P; Horakova Z; Slampa P; Slaby O
    Head Neck; 2019 Apr; 41(4):940-949. PubMed ID: 30552846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
    Niranjan KC; Raj M; Hallikeri K
    Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.
    Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K
    Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of FaDu-R, a radioresistant head and neck cancer cell line, and cancer stem cells.
    Cho KJ; Park EJ; Kim MS; Joo YH
    Auris Nasus Larynx; 2018 Jun; 45(3):566-573. PubMed ID: 28844650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
    Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
    Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD44 in Head and Neck Squamous Cell Carcinoma-An
    Kavitha L; Vijayashree Priyadharsini J; Kattula D; Rao UKM; Balaji Srikanth R; Kuzhalmozhi M; Ranganathan K
    Glob Med Genet; 2023 Sep; 10(3):221-228. PubMed ID: 37593530
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
    Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field.
    Su Z; Liu D; Chen L; Zhang J; Ru L; Chen Z; Gao Z; Wang X
    Int J Nanomedicine; 2019; 14():7549-7560. PubMed ID: 31571863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
    Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
    Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
    Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
    Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
    Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
    Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.